2Maswadeh H, Demetzos C, Dimas K, et al. In vitro eytotoxic/cy'tostatic activity of anionic liposomes containing vinblastine against leukaemic human cell lines [J]. J Pharmacy and Pharmacology ,2002,54(2) : 189-196.
3Paola C, Maurizio C, Paola B, et al. Preparation,characterization and property of sterically stabilized paclitaxelcontaining liposomes[J]. J Controlled Release, 2000,63:19-30.
4Mei Z N, Chen H B, Weng T, et al. Solid lipid nanoparticles and microemulsion for topical delivery of triptolide[J]. Eur J Pharm Biopharm ,2003,56(2) : 189-196.
5Yang S C, Lu L F, Cai Y, et al. Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain[J]. J Controlled Release, 1999, 59: 299-307.
6Fenart L, CeccheUi R, Dehouck B, et al. In vitro model for evaluating drug transport across the blood-brain barrier[ J].Adv Drug Del Rev, 1999,36:165-178.
7Radtke M, Mtiller R H. NLC-nanostructured lipid carrier: the new generation of lipid drug carriers[ J ]. New Drugs, 2001,2:48-52.
8Olbrich C, Geβner A, Kayser O, et al. Lipid-drug conjugate(LDC) nanoparticles as novel earriersystem for hydrophilic anfitrypanosomal drug diminazenediaceturate [ J ]. J Drug Target, 2002, 10(5):387-396.
9Wissing S A, Kayser O, Mtiller R H. Solid lipid nanoparticles for parenteral drug delivery[ J ]. Adv Drug Del Rev,2004, 56:1257-1272.
10Jenning V, Thtinemannb A F, Gohla S H, et al. Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of fiquid and solid lipids[J], Inter J Pharm, 2000, 199:167-177.
